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dermatologist and the pathologist [3, 4] . The historical classification into lentigo maligna melanoma, superficial spreading melanoma, nodular melanoma, and acral lentiginous melanoma is still an acceptable start point [5, 6] . The WHO 2006 classification recognizes additional subtypes of melanoma [2] , but is still incomplete ( Table 1 ). The histological diagnosis of melanocytic lesions requires assessment of architectural and cytological features. Histological features that favor a diagnosis of melanoma include asymmetry, ulceration, cytological atypia, pagetoid involvement of the epidermis, lack of maturation, and dermal mitosis with deep and atypical ones. Optimal evaluation of any melanocytic lesion requires complete excision that incorporates the full lesion instead of incorporating the full thickness of the involved lesion removed intact [4, 5] . Because of the lack of objective and reproducible diagnostic criteria, ancillary techniques such as immunohistochemistry have been increasingly implemented in routine practice. However, immunohistochemistry must be always evaluated in the morphological context, because any single immunostain is not able to give clear-cut information for a differential diagnosis between nevus and melanoma, because there are still no reliable markers that are both highly sensitive and specific for melanoma diagnosis [6] . Moreover, molecular techniques are being increasingly proposed with the aim of looking for specific pathways toward melanoma genesis [5, 6] , but histopathology remains the major source of the most reproducible tool for diagnosis and prognosis in melanoma. Mandatory 
